Ribociclib could offer hope for breast cancer treatment

New research found the medication, marketed under the name Kisqali, can lower chances of recurrence for many of those diagnosed with earlier stages of breast cancer.
2:03 | 06/02/23

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for Ribociclib could offer hope for breast cancer treatment
'L S F WR S F WRE F WRE SG AL MUL AMEIS. LGAL MUL AMEIS. LG SAL MUL AMEIS. LG S FAL MUL AMEIS. LG S FED MUL AMEIS. LG S FED>>UL AMEIS. LG S FED>>S AMEIS. LG S FED>>S D.MEIS. LG S FED>>S D.FOIS. LG S FED>>S D.FOED. LG S FED>>S D.FOEDITAS GIS T S FED>>S D.FOEDITAS GIS T EF FED>>S D.FOEDITAS GIS T EFHEED>>S D.FOEDITAS GIS Y. Y. FFT CAC WAER N FFT CAC WAER N TFT CAC WAER N TIS CAC WAER N TISNGAC WAER N TISNGXC WAER N TISNGXCEWAER N TISNGXCEW OR N TISNGXCEW OS DLYTA C TISNGXCEW OS DLYTA CA>ISNGXCEW OS DLYTA CA>> NGXCEW OS DLYTA CA>> X.XCEW OS DLYTA orRERU COWEOFEC FNOOWTATHSEOS AL DHTHUTTUDDHI DHTHUTTUDDHI EDHEILCEK TAN EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTO EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTL EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTR EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTH EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTW EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTC EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTE EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTA EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUT EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUT. EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTI EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTB EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTE EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTI EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTN EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTR EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTD EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTH EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTO EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUT. EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUT EDHEILCEK TAN S. WHOEAVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN HE WHOEAVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN HE THOEAVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN HE TNDEAVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN HE TNDTRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN EN TNDTRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN ENGANDTRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN ENGAU TRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN ENGAU WRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN MGAU WRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN MROU WRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN MRO FWRVCUEV5EA AFRTINO F ARUTM EDHEILCEK TAN MRO FLOVCUEV5EA AFRTINO F ARUTM LEOUOLYO A E M R O RE ANE AHEE. H TWS LEOUOLYO A E M R O RE SEE AHEE. H TWS LEOUOLYO A E M R O RE SEA AHEE. H TWS SEA AHEE. H TWS WEDASTH M

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"2:03","description":"New research found the medication, marketed under the name Kisqali, can lower chances of recurrence for many of those diagnosed with earlier stages of breast cancer.","mediaType":"default","section":"ABCNews/GMA","id":"99784239","title":"Ribociclib could offer hope for breast cancer treatment","url":"/GMA/Wellness/video/ribociclib-offer-hope-breast-cancer-treatment-99784239"}